Literature DB >> 32178454

The Roles of miRNA in Glioblastoma Tumor Cell Communication: Diplomatic and Aggressive Negotiations.

Andrei Buruiană1, Ștefan Ioan Florian2,3, Alexandru Ioan Florian2,3, Teodora-Larisa Timiș4, Carmen Mihaela Mihu5, Maria Miclăuș6, Sergiu Oșan1, Iona Hrapșa1, Radu Constantin Cataniciu1, Marius Farcaș1,7, Sergiu Șușman5,8.   

Abstract

Glioblastoma (GBM) consists of a heterogeneous collection of competing cellular clones which communicate with each other and with the tumor microenvironment (TME). MicroRNAs (miRNAs) present various exchange mechanisms: free miRNA, extracellular vesicles (EVs), or gap junctions (GJs). GBM cells transfer miR-4519 and miR-5096 to astrocytes through GJs. Oligodendrocytes located in the invasion front present high levels of miR-219-5p, miR-219-2-3p, and miR-338-3p, all related to their differentiation. There is a reciprocal exchange between GBM cells and endothelial cells (ECs) as miR-5096 promotes angiogenesis after being transferred into ECs, whereas miR-145-5p acts as a tumor suppressor. In glioma stem cells (GSCs), miR-1587 and miR-3620-5p increase the proliferation and miR-1587 inhibits the hormone receptor co-repressor-1 (NCOR1) after EVs transfers. GBM-derived EVs carry miR-21 and miR-451 that are up-taken by microglia and monocytes/macrophages, promoting their proliferation. Macrophages release EVs enriched in miR-21 that are transferred to glioma cells. This bidirectional miR-21 exchange increases STAT3 activity in GBM cells and macrophages, promoting invasion, proliferation, angiogenesis, and resistance to treatment. miR-1238 is upregulated in resistant GBM clones and their EVs, conferring resistance to adjacent cells via the CAV1/EGFR signaling pathway. Decrypting these mechanisms could lead to a better patient stratification and the development of novel target therapies.

Entities:  

Keywords:  glioblastoma; intercellular communication; miRNA; tumor microenvironment

Year:  2020        PMID: 32178454     DOI: 10.3390/ijms21061950

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  20 in total

Review 1.  The Involvement of Long Non-Coding RNAs in Glioma: From Early Detection to Immunotherapy.

Authors:  Xiaoben Wu; Lei Yang; Jing Wang; Yingying Hao; Changyin Wang; Zhiming Lu
Journal:  Front Immunol       Date:  2022-05-10       Impact factor: 8.786

2.  Human Microglia Extracellular Vesicles Derived from Different Microglia Cell Lines: Similarities and Differences.

Authors:  Lorenzo Ceccarelli; Laura Marchetti; Milena Rizzo; Aldo Moscardini; Valentina Cappello; Eleonora Da Pozzo; Miriam Romano; Chiara Giacomelli; Paolo Bergese; Claudia Martini
Journal:  ACS Omega       Date:  2022-06-28

3.  Study on the mechanism of let-7a-5p in regulating the proliferation in cervical cancer cells.

Authors:  Zhiqin Chen; Jiahui Qiu; Yuling Gao; Qin Lu; Ying Lin; Hong Shi
Journal:  Clin Transl Oncol       Date:  2022-03-18       Impact factor: 3.340

4.  CKAP2L Knockdown Exerts Antitumor Effects by Increasing miR-4496 in Glioblastoma Cell Lines.

Authors:  Yao-Feng Li; Wen-Chiuan Tsai; Chung-Hsing Chou; Li-Chun Huang; Shih-Ming Huang; Dueng-Yuan Hueng; Chia-Kuang Tsai
Journal:  Int J Mol Sci       Date:  2020-12-27       Impact factor: 5.923

Review 5.  Molecular and Cellular Complexity of Glioma. Focus on Tumour Microenvironment and the Use of Molecular and Imaging Biomarkers to Overcome Treatment Resistance.

Authors:  Silvia Valtorta; Daniela Salvatore; Paolo Rainone; Sara Belloli; Gloria Bertoli; Rosa Maria Moresco
Journal:  Int J Mol Sci       Date:  2020-08-06       Impact factor: 5.923

6.  Analysis of Serum miRNA in Glioblastoma Patients: CD44-Based Enrichment of Extracellular Vesicles Enhances Specificity for the Prognostic Signature.

Authors:  Theophilos Tzaridis; Katrin S Reiners; Johannes Weller; Daniel Bachurski; Niklas Schäfer; Christina Schaub; Michael Hallek; Björn Scheffler; Martin Glas; Ulrich Herrlinger; Stefan Wild; Christoph Coch; Gunther Hartmann
Journal:  Int J Mol Sci       Date:  2020-09-29       Impact factor: 5.923

7.  Long Noncoding RNA OIP5-AS1 Promotes the Disease Progression in Nasopharyngeal Carcinoma by Targeting miR-203.

Authors:  Jian Tang; Chengxiao Fu; Yanwen Li; Shuangqin Chen; Xiaoxin Jiang; Wenqian Xu; Haitao Xie
Journal:  Biomed Res Int       Date:  2021-02-05       Impact factor: 3.411

8.  Inhibition of circular RNA_0000285 prevents cell proliferation and induces apoptosis in thyroid cancer by sponging microRNA-654-3p.

Authors:  Rongjun Gao; Hui Ye; Qingjun Gao; Nanpeng Wang; Yan Zhou; Haisong Duan
Journal:  Oncol Lett       Date:  2021-07-19       Impact factor: 2.967

Review 9.  Multiple Faces of the Glioblastoma Microenvironment.

Authors:  Alina Simona Șovrea; Bianca Boșca; Carmen Stanca Melincovici; Anne-Marie Constantin; Andreea Crintea; Mariana Mărginean; Eleonora Dronca; Mihaela Elena Jianu; Rada Suflețel; Diana Gonciar; Maria Bungărdean; Carmen-Bianca Crivii
Journal:  Int J Mol Sci       Date:  2022-01-06       Impact factor: 5.923

Review 10.  Role of MicroRNAs in the Development and Progression of the Four Medulloblastoma Subgroups.

Authors:  Emilia Bevacqua; Jasmin Farshchi; Maria Victoria Niklison-Chirou; Paola Tucci
Journal:  Cancers (Basel)       Date:  2021-12-16       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.